Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 23 other studies
422people in the Effect of Liraglutide on Long-term Weight Maintenance and Additional Weight Loss Induced by a 4 to 12 Week Low Calorie Diet in Obese Subjects; A 56 Week Randomised, Double-blind, Placebo Controlled, Parallel Group, Multicentre Trial With a 12 Week Follow-up Period trial, from 2008
of them with obesity, in this paper
Among Hispanic, the trial randomly assignedassigned by chance
liraglutide 3.0 mg
placebo
May have lowered weight loss−5.10
randomised · one subgroupAmong non-Hispanic, the trial randomly assignedassigned by chance
liraglutide 3.0 mg
placebo
May have lowered weight loss−5.20
randomised · one subgroupthe abstract, start to end
… 7.0% versus 1.5%, treatment difference -5.1% (95% CI, -6.2 to -4.0); non-Hispanics 7.5% versus 2.3%, -5.2% (95% CI, -5.5 to -4.8).
← favours treatmentfavours comparator →
could be chanceMean weight lossliraglutide 3.0 mg vs placebo, in Hispanic
−5.1−6.20 to −4.00
Mean weight lossliraglutide 3.0 mg vs placebo, in non-Hispanic
−5.2−5.50 to −4.80
GLP-1 receptor agonistsBody weight & composition
GLP-1 receptor agonists × body weight & compositionhelps?replicated
unlikelylikely
0.900.90 without it
← favours treatmentfavours comparator →
1 / 6